SMITH ASSET MANAGEMENT GROUP LP - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 316 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
SMITH ASSET MANAGEMENT GROUP LP ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2021$9,000
+28.6%
1100.0%0.00%
Q1 2021$7,000
-97.2%
110
-96.7%
0.00%
-100.0%
Q4 2020$253,000
+76.9%
3,300
-0.3%
0.02%
+114.3%
Q3 2020$143,0000.0%3,3100.0%0.01%
-12.5%
Q2 2020$143,000
+47.4%
3,310
-1.5%
0.01%
+60.0%
Q1 2020$97,000
-54.5%
3,3600.0%0.01%
-44.4%
Q4 2019$213,000
+124.2%
3,3600.0%0.01%
+200.0%
Q3 2019$95,0003,3600.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2021
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,346$62,945,00041.38%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$250,206,00032.27%
Aquilo Capital Management, LLC 365,926$28,078,0005.84%
L1 Capital Pty Ltd 298,687$23,127,0004.32%
First Light Asset Management, LLC 704,449$54,052,0004.00%
ACUTA CAPITAL PARTNERS, LLC 139,000$10,665,0002.90%
Evolutionary Tree Capital Management, LLC 48,265$3,703,0002.82%
Parkman Healthcare Partners LLC 127,171$9,758,0002.50%
Capital Impact Advisors, LLC 88,183$6,766,0001.66%
Tri Locum Partners LP 56,003$4,297,0001.56%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders